| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Trevi Therapeutics, Inc. (TRVI) has 2 insiders with recent SEC Form 4 filings, including 12 buys and 0 sells. TRVI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 375.0K | $6.94M | - | |
| Other | 26.1K | $482.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 11, 2022 | Chang Carmen47 | 10% Owner | Buy | 3,580,526 | $1.90 | $6,802,999.40 | +46.0% | +31.2% | -32.7% | |
| Apr 11, 2022 | Behbahani Ali47 | 10% Owner | Buy | 3,580,526 | $1.90 | $6,802,999.40 | +46.0% | +31.2% | -32.7% | |
| Apr 11, 2022 | Baskett Forest53 | 10% Owner | Buy | 2,631,578 | $1.90 | $4,999,998.20 | +33.8% | +31.2% | -32.7% | |
| Apr 11, 2022 | New Enterprise Associates 16, L.P. | 10% Owner | Buy | 2,631,578 | $1.90 | $4,999,998.20 | +33.8% | +31.2% | -32.7% | |
| Oct 18, 2021 | Walker Paul Edward47 | 10% Owner | Buy | 1,851,852 | $0.00 | - | +31.2% | -40.8% | +62.7% | |
| Oct 18, 2021 | Sonsini Peter W. | 10% Owner | Buy | 1,851,852 | $0.00 | - | +31.2% | -40.8% | +62.7% | |
| Oct 18, 2021 | Sandell Scott D55 | 10% Owner | Buy | 1,851,852 | $0.00 | - | +31.2% | -40.8% | +62.7% | |
| Oct 18, 2021 | Florence Anthony A. Jr.56 | 10% Owner | Buy | 1,851,852 | $0.00 | - | +31.2% | -40.8% | +62.7% | |
| Oct 18, 2021 | Chang Carmen47 | 10% Owner | Buy | 1,851,852 | $0.00 | - | +31.2% | -40.8% | +62.7% | |
| Oct 18, 2021 | New Enterprise Associates 16, L.P. | 10% Owner | Buy | 1,851,852 | $0.00 | - | +31.2% | -40.8% | +62.7% |